CSIMarket
 
Medtronic Plc  (MDT)
Other Ticker:  
 
 

Medtronic Plc's Suppliers Performance

MDT's Supply Chain

 
MDT Costs vs Sales of Suppliers Growth Revenues of Medtronic Plc's Suppliers, deteriorated by -12.72 % compared to the same quarter a year ago, from the previous quarter, sales fell by -8.2 %, Medtronic Plc recorded an increase in cost of sales by 3.46 % year on year, sequentially cost of sales grew by 0.76 % in Q4.

More on MDT Suppliers




Medtronic Plc's Suppliers realized a deteriorated in sales by -12.72 % compared to the same quarter a year ago, from the previous quarter, sales fell by -8.2 %, Medtronic Plc recorded increase in cost of sales by 3.46 % year on year, sequentially cost of sales grew by 0.76 % in Q4.

More on MDT Suppliers



  News about Medtronic Plc Contracts



Medtronic Plc's Comment on Supply Chain


We manufacture most of our products at 41 manufacturing facilities located in various countries throughout the world. The largest of these manufacturing facilities are located in Arizona, California, Colorado, Connecticut, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany, Ireland, Italy, Mexico, The Netherlands, The Peoples Republic of China, Singapore, and Switzerland. We purchase many of the components and raw materials used in manufacturing these products from numerous suppliers in various countries. For reasons of quality assurance, sole source availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. We work closely with our suppliers to help ensure continuity of supply while maintaining high quality and reliability. Due to the U.S. FDA’s requirements regarding manufacturing of our products, we may not be able to quickly establish additional or replacement sources for certain components or materials. Generally, we have been able to obtain adequate supplies of such raw materials and components. However, a sudden or unexpected reduction or interruption in supply, and an inability to develop alternative sources for such supply, could adversely affect our operations. Moreover, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank), the SEC has implemented reporting and disclosure requirements related to the use of certain minerals, known as "conflict minerals": tantalum, tin, tungsten (or their ores), and gold; which are mined from the Democratic Republic of the Congo and adjoining countries. Pursuant to these requirements, we are required to report on Form SD the procedures we employ to determine the sourcing of such minerals and metals produced from those minerals. There are costs associated with complying with these disclosure requirements, including for diligence in regards to the sources of any conflict minerals used in our products, in addition to the cost of remediation and other changes to products, processes, or sources of supply as a consequence of such verification activities. In addition, the implementation of these rules could adversely affect the sourcing, supply, and pricing of materials used in our products. As of the date of our conflict minerals report for the 2013 calendar year, we were unable to obtain the necessary information on conflict minerals from all of our suppliers and were unable to determine that all of our products are conflict free. We may continue to face difficulties in gathering this information in the future. We may face reputational challenges if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to sufficiently verify the origins for all conflict minerals used in our products through the procedures we implement.

Medtronic Plc's Comment on Supply Chain


We manufacture most of our products at 41 manufacturing facilities located in various countries throughout the world. The largest of these manufacturing facilities are located in Arizona, California, Colorado, Connecticut, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany, Ireland, Italy, Mexico, The Netherlands, The Peoples Republic of China, Singapore, and Switzerland. We purchase many of the components and raw materials used in manufacturing these products from numerous suppliers in various countries. For reasons of quality assurance, sole source availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. We work closely with our suppliers to help ensure continuity of supply while maintaining high quality and reliability. Due to the U.S. FDA’s requirements regarding manufacturing of our products, we may not be able to quickly establish additional or replacement sources for certain components or materials. Generally, we have been able to obtain adequate supplies of such raw materials and components. However, a sudden or unexpected reduction or interruption in supply, and an inability to develop alternative sources for such supply, could adversely affect our operations. Moreover, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank), the SEC has implemented reporting and disclosure requirements related to the use of certain minerals, known as "conflict minerals": tantalum, tin, tungsten (or their ores), and gold; which are mined from the Democratic Republic of the Congo and adjoining countries. Pursuant to these requirements, we are required to report on Form SD the procedures we employ to determine the sourcing of such minerals and metals produced from those minerals. There are costs associated with complying with these disclosure requirements, including for diligence in regards to the sources of any conflict minerals used in our products, in addition to the cost of remediation and other changes to products, processes, or sources of supply as a consequence of such verification activities. In addition, the implementation of these rules could adversely affect the sourcing, supply, and pricing of materials used in our products. As of the date of our conflict minerals report for the 2013 calendar year, we were unable to obtain the necessary information on conflict minerals from all of our suppliers and were unable to determine that all of our products are conflict free. We may continue to face difficulties in gathering this information in the future. We may face reputational challenges if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to sufficiently verify the origins for all conflict minerals used in our products through the procedures we implement.


MDT's Suppliers Net profit fell by MDT's Suppliers Net margin fell in Q4 to
-43.05 % 7.55 %


Medtronic Plc's Suppliers Sales Growth in Q4 2023 by Industry

Suppliers from Chemical Manufacturing Industry -2.89 %   
Suppliers from Chemicals - Plastics & Rubber Industry -11.33 %   
Suppliers from Iron & Steel Industry      5.91 %
Suppliers from Miscellaneous Fabricated Products Industry -60.39 %   
Suppliers from Industrial Machinery and Components Industry      0.3 %
Suppliers from Conglomerates Industry -1.32 %   
Suppliers from Oil & Gas Integrated Operations Industry -13.42 %   
Suppliers from Medical Equipment & Supplies Industry -0.82 %   
Suppliers from Electronic Instruments & Controls Industry -3.12 %   
Suppliers from Semiconductors Industry -8.79 %   
Suppliers from Software & Programming Industry -39.18 %   
     
• MDT Suppliers Valuation • MDT Suppliers Mgmt. Effect.





MDT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Medtronic Plc 111,410.02 32,319.00 4,234.00 95,000
Couchbase Inc 1,293.86 139.27 -65.13 646
Eltek Ltd 61.44 33.82 5.04 0
Elastic N v 10,563.19 1,211.06 56.09 2,978
Interlink Electronics inc 74.84 10.41 1.08 89
Mongodb Inc 25,310.77 1,284.04 -345.40 2,539
Alcoa Corp 5,545.79 10,619.00 -966.00 61,000
Arconic Corporation 3,050.71 8,141.00 -254.00 0
Ati Inc 6,998.22 4,173.60 423.40 9,700
Dmc Global Inc 435.95 719.05 34.76 428
Calumet Specialty Products Partners l p 1,143.55 4,202.70 362.70 2,000
Chevron Corp 292,337.70 200,949.00 21,411.00 42,595
Dow Inc 40,971.41 44,622.00 660.00 35,700
Eastman Chemical Co 11,016.85 9,210.00 896.00 14,000
Haynes International inc 760.32 603.80 41.94 1,123
Helen Of Troy Limited 2,783.98 2,082.07 162.55 1,610
Ipg Photonics Corp 4,124.17 1,286.70 218.88 5,960
Illinois Tool Works Inc 80,332.04 16,107.00 2,957.00 45,000
Nlight Inc 574.58 209.11 -41.67 1,300
Lightpath Technologies Inc 56.25 32.49 -5.03 342
Liquidmetal Technologies Inc 55.04 0.51 -2.05 26
Mueller Industries Inc 5,960.72 3,420.35 609.65 4,244
3m Company 58,042.44 32,681.00 -6,979.00 95,000
Materion Corporation 2,706.61 1,665.04 95.70 2,550
Ingevity Corporation 1,629.72 1,691.90 -5.40 1,500
Ryerson Holding Corporation 1,092.70 5,284.10 96.60 3,000
Stepan Company 1,966.02 2,419.82 52.23 2,073
Trecora Resources 231.52 301.32 8.99 310
Trinseo Plc 171.09 3,474.50 -946.70 2,197
Universal Stainless and Alloy Products Inc 199,014.71 261.94 -1.41 645
Viavi Solutions Inc 2,203.71 1,006.40 -29.10 3,500
Vystar Corporation 0.77 -1.37 -3.42 1
Wolfspeed Inc 3,275.70 868.60 -620.40 4,017
Worthington Industries Inc 3,153.79 4,700.98 303.63 10,500
Exxon Mobil Corporation 454,884.48 344,582.00 37,354.00 63,000
Solitario Resources Corp 30.83 0.19 -3.38 5
SUBTOTAL 1,221,855.47 707,993.39 55,483.15 419,578


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com